statements

Jeevan Scientific Technology Ltd.

BSE: 538837

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Research, Analytics & Technology

81.35-0.3 (-0.37%)

23 Oct, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Jeevan Scientific Technology Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	3.35	1.26	6.37	13.45	17.39	18.21	20.40	26.13	24.90	47.48	67.79	36.18	39.65	46.84	61.54	71.02
Cost of Operating Revenue	0.29	0.28	-	0.28	0.83	1.38	3.42	4.77	4.79	4.61	11.08	8.08	9.75	10.05	11.52	12.42
Gross Profit	3.06	0.98	6.37	13.17	16.56	16.83	16.98	21.35	20.11	42.87	56.71	28.10	29.90	36.79	50.02	58.59
Gross Margin	91.3	77.7	100.0	97.9	95.2	92.4	83.2	81.7	80.8	90.3	83.7	77.7	75.4	78.5	81.3	82.5
Total Operating Expenses	2.93	2.93	5.58	11.36	16.30	16.37	19.10	23.83	34.23	33.54	54.73	39.96	40.96	45.68	58.36	63.07
Operating Profit	0.42	-1.67	0.79	2.08	1.09	1.84	1.30	2.29	-9.33	13.94	13.07	-3.78	-1.31	1.16	3.17	7.95
Operating Margin	12.6	-132.0	12.3	15.5	6.3	10.1	6.4	8.8	-37.5	29.4	19.3	-10.5	-3.3	2.5	5.2	11.2
Financing Income/(Expense) - Net	-0.40	-0.58	-0.66	-0.74	-1.28	-1.41	-1.86	-1.90	-2.79	-2.16	-0.96	-0.97	-0.97	-1.76	-2.04	-1.94
Profit before Taxes	0.04	-2.21	0.23	1.44	0.22	1.01	0.36	1.37	-10.54	13.65	18.03	-3.68	-1.60	0.05	2.09	6.80
Income Taxes	0.00	-	-	-	0.22	0.11	0.25	0.25	-1.96	1.91	6.08	-0.62	-0.28	-0.01	1.06	1.68
Profit after Tax	0.04	-2.21	0.23	1.44	-0.01	0.90	0.11	1.11	-8.59	11.74	11.94	-3.06	-1.30	0.13	1.15	3.62
PAT Margin	1.1	-175.4	3.6	10.7	-	5.0	0.5	4.3	-34.5	24.7	17.6	-8.5	-3.3	0.3	1.9	5.1
EPS - Basic - ex Extraordinary Items	0.06	-3.67	0.38	2.38	-0.01	0.97	0.10	0.74	-5.61	7.67	7.81	-1.98	-0.84	0.08	0.58	2.15
EPS - Diluted - ex Extraordinary Items	0.06	-3.67	0.38	2.38	-0.01	0.97	0.10	0.74	-5.61	7.67	7.81	-1.98	-0.84	0.08	0.58	2.14
EBIT	0.42	-1.67	0.79	2.08	1.09	1.84	1.30	2.29	-9.33	13.94	13.07	-3.78	-1.31	1.16	3.17	7.95
EBITDA	0.64	-1.40	1.06	2.36	1.77	3.07	3.82	5.74	-5.41	17.91	16.76	1.29	4.62	7.41	9.82	14.55
EBITDA Margin	19.1	-110.9	16.6	17.6	10.2	16.8	18.7	22.0	-21.7	37.7	24.7	3.6	11.6	15.8	16.0	20.5

Balance Sheet

Abridged

Understanding Balance Sheet

Jeevan Scientific Technology Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	R 2018 Mar 31	R 2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	IR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	4.98	4.11	5.09	10.24	8.77	13.97	20.44	24.88	18.08	33.87	53.94	29.19	24.67	28.76	49.87
Long-Term Investments	-	-	-	-	-	-	1.03	-	-	-	-	0.64	0.73	0.78	3.85
Property Plant & Equipment - Net	1.76	1.52	1.31	5.66	8.17	10.62	18.00	19.58	17.74	15.88	14.10	20.84	23.94	32.39	33.73
Total Non-Current Assets	3.86	3.65	2.79	6.71	9.42	16.92	28.86	36.42	35.80	32.11	23.94	36.73	43.19	49.53	56.72
Total Assets	8.84	7.76	7.88	16.95	18.20	30.89	49.29	61.30	53.88	65.98	77.88	65.92	67.87	78.29	106.59
Total Current Liabilities	4.02	5.37	5.10	7.74	8.29	9.19	16.54	21.43	22.49	22.87	22.15	11.39	9.21	12.07	19.89
Long Term Debt	0.47	0.25	0.10	4.14	8.32	4.75	9.84	7.47	7.90	7.77	4.37	5.80	9.62	15.59	12.97
Total Non-Current Liabilities	0.49	0.28	0.44	5.43	8.35	4.82	10.05	8.04	8.16	8.09	5.15	6.11	10.03	16.15	13.74
Total Liabilities	4.51	5.64	5.54	13.18	16.63	14.02	26.59	29.47	30.65	30.95	27.30	17.50	19.23	28.22	33.64
Total Shareholders' Equity	4.33	2.11	2.34	3.78	1.56	16.88	22.70	31.83	23.22	35.02	50.58	48.19	48.43	49.94	71.72
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	0.23	0.20	0.13	1.23
Total Equity	4.33	2.11	2.34	3.78	1.56	16.88	22.70	31.83	23.22	35.02	50.58	48.42	48.63	50.07	72.95
Total Liabilities & Equity	8.84	7.76	7.88	16.95	18.20	30.89	49.29	61.30	53.88	65.98	77.88	65.92	67.87	78.29	106.59

Cash Flow

Abridged

Understanding Cash Flow Statement

Jeevan Scientific Technology Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	0.25	-1.95	0.50	1.71	0.92	2.22	2.89	4.81	-4.66	15.77	22.94	-1.52	4.05	7.35	9.52
Working Capital - Increase/(Decrease)	-2.40	1.25	-0.23	0.67	2.63	-7.83	2.76	-0.78	4.65	-10.82	4.15	-7.39	-1.63	1.42	-10.99
Net CF from Operating Activities	-2.14	-0.70	0.27	2.39	3.55	-5.62	5.65	4.04	-0.01	4.95	27.09	-8.91	2.43	8.78	-1.47
Capital Expenditures - Net	0.56	0.06	0.03	4.59	3.63	8.90	14.35	7.87	1.90	0.80	2.23	8.16	12.03	16.03	8.18
Net CF from Investing Activities	-0.56	-0.06	-0.03	-4.59	-3.63	-8.90	-14.35	-7.87	-1.90	-0.80	-2.23	-7.88	-12.03	-16.08	-10.14
Dividends Paid - Cash - Total	-	-	-	-	-	-	-	-	-	-	-	1.84	-	-	-
Stock - Issuance/(Retirement) - Net	-	-	-	-	-	14.55	4.77	8.45	-	-	2.63	0.43	-	0.35	19.84
Debt - LT & ST - Issuance/(Retirement) - Total	2.70	0.75	-0.22	2.21	0.23	0.01	5.09	-2.37	0.44	-0.13	-3.40	-7.16	3.31	6.65	1.03
Net Cash Flow from Financing Activities	2.70	0.75	-0.22	2.21	0.23	14.57	9.86	6.08	0.44	-0.13	-0.77	-6.09	3.31	7.01	20.87
Free Cash Flow to Equity	0.00	0.00	0.03	0.01	0.15	-14.51	-3.61	-6.21	-1.47	4.02	21.46	-24.24	-6.29	-0.60	-8.62
Free Operating CF net dividend	-2.70	-0.76	0.25	-2.20	-0.15	-14.52	-8.70	-3.83	-2.00	4.15	24.75	-18.91	-9.60	-7.26	-9.65
Free Operating CF	-2.70	-0.76	0.25	-2.20	-0.15	-14.52	-8.70	-3.83	-2.00	4.15	24.75	-17.07	-9.60	-7.26	-9.65

Business Segment Analysis

Jeevan Scientific Technology Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Jeevan Scientific Technology Ltd.

Regional Segment Analysis

Jeevan Scientific Technology Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Jeevan Scientific Technology Ltd.

Historical Segment Analysis

Track how Jeevan Scientific Technology Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

We don't have enough data to show segments for Jeevan Scientific Technology Ltd.

Frequently Asked Questions

What is the revenue of Jeevan Scientific Technology Ltd.?

The latest trailing twelve month revenue of Jeevan Scientific Technology Ltd. is ₹ 71.02 Cr, reflecting a 1-year growth of 66.07% and a 3-year CAGR of 25.13%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Jeevan Scientific Technology Ltd.?

The latest trailing twelve month net profit (PAT) of Jeevan Scientific Technology Ltd. is ₹ 3.81 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Jeevan Scientific Technology Ltd.?

The trailing twelve month EBITDA of Jeevan Scientific Technology Ltd. is approximately ₹ 3.66 Cr (based on an operating margin of 5.16%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Jeevan Scientific Technology Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Jeevan Scientific Technology Ltd. is 0.52. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Jeevan Scientific Technology Ltd.?

The debt-to-equity ratio of Jeevan Scientific Technology Ltd. stands at 0.30. The interest coverage ratio is 4.09x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Jeevan Scientific Technology Ltd.?

The estimated book value per share of Jeevan Scientific Technology Ltd. is 35.83 (derived from a P/B ratio of 2.27 and market price of ₹ 81.35), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Jeevan Scientific Technology Ltd.?

The trailing twelve month operating cash flow of Jeevan Scientific Technology Ltd. is ₹ -1.47 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Jeevan Scientific Technology Ltd. report consolidated or standalone financials?

Jeevan Scientific Technology Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.